The global NK cell therapeutics market is an emerging market and is growing exponentially. To overcome the challenges associated with the high cost of immunotherapies, the focus of the researchers and biopharmaceutical companies is now shifting toward cost-effective and safe NK cell therapeutics. The CAR T-cell therapies are produced on the basis of patient specificity. Hence, the manufacturing...